Findings Published for Forest Devices’ AlphaStroke Detection Technology

February 23, 2021—Forest Devices, Inc. announced the publication of positive results from the EDGAR study of its AlphaStroke technology in identifying patients with large vessel occlusive (LVO) strokes in emergency departments. The device is designed to support prehospital health care providers, such as emergency medical technicians (EMTs), in identifying stroke.

According to the company, the study showed that AlphaStroke was 28% to 40% superior to the clinical exams currently used by medics in the field to make triage decisions at correctly identifying patients with LVO, and equally good as the clinical exams, at correctly ruling out patients with non-LVO diagnoses.

The study, “Portable Neuromonitoring Device Detects Large Vessel Occlusion in Suspected Acute Ischemic Stroke,” by Paulina B. Sergot, MD, et al is available online in Stroke.

“The EDGAR study shows AlphaStroke has the potential to dramatically improve the detection of large vessel occlusion stroke in the prehospital environment,” commented Dr. Sergot in the company’s press release.

The study’s Senior Investigator, W. Frank Peacock, MD, added, “This technology will be a game-changer in the prehospital. Easy, fast, and more accurate than clinical impression for the diagnosis of LVO, using AlphaStroke on ambulances will mean more stroke victims getting to the right hospital as soon as possible. Time is brain, and fast treatment is the only thing that can prevent death or permanent disability from stroke.”

Forest Devices also highlighted that the EDGAR study is the first study of a portable LVO identification technology that has been shown to outperform clinical exams currently in use in the field.